Published in QJM on October 01, 2002
Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol (2007) 2.43
Granulomatous disease in common variable immunodeficiency. Clin Immunol (2009) 2.07
Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol (2007) 1.72
Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol (2011) 1.60
Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol (2007) 1.58
The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol (2007) 1.41
Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev (2009) 1.38
Primary antibody deficiency and diagnostic delay. J Clin Pathol (2005) 1.09
Educational paper: primary antibody deficiencies. Eur J Pediatr (2011) 1.00
Immunodeficiencies. Clin Exp Immunol (2009) 0.96
CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters. J Clin Immunol (2014) 0.93
Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice. J Clin Immunol (2013) 0.88
Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency. Clin Exp Immunol (2009) 0.88
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study. J Allergy Clin Immunol (2016) 0.88
The spectrum of disease manifestations in patients with common variable immunodeficiency disorders and partial antibody deficiency in a university hospital. J Clin Immunol (2012) 0.84
Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr (2014) 0.84
Deficiency of somatic hypermutation of immunoglobulin G transcripts is a better predictor of severe respiratory tract infections than lack of memory B cells in common variable immunodeficiency. J Clin Immunol (2005) 0.82
Common variable immunodeficiency complicated with hemolytic uremic syndrome. Ups J Med Sci (2011) 0.81
Examining the use of ICD-9 diagnosis codes for primary immune deficiency diseases in New York State. J Clin Immunol (2012) 0.81
Organising pneumonia in common variable immunodeficiency. BMJ Case Rep (2013) 0.80
Activity, severity and impact of respiratory disease in primary antibody deficiency syndromes. J Clin Immunol (2013) 0.80
Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency. Clin Exp Immunol (2011) 0.80
Common variable immune deficiency in children--clinical characteristics varies depending on defect in peripheral B cell maturation. J Clin Immunol (2013) 0.79
Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis. Clin Exp Immunol (2015) 0.79
Bringing immunoglobulin knowledge up to date: how should we treat today? Clin Exp Immunol (2011) 0.78
Difficult-to-control asthma management through the use of a specific protocol. Clinics (Sao Paulo) (2010) 0.78
FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Exp Immunol (2016) 0.76
Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study. Mayo Clin Proc (2013) 0.76
Bilateral lung transplantation in a patient with humoral immune deficiency: a case report with review of the literature. Case Reports Immunol (2014) 0.75
Reduced immunoglobulin M is associated with sinus mucosal thickening, osteitis and sinus surgery in patients with common variable immunodeficiency. Int Arch Allergy Immunol (2009) 0.75
An unsual case of persistent inguinal swelling - beware immunodeficiency. JRSM Short Rep (2011) 0.75
[Humoral immunodeficiency : awareness for better support]. Pan Afr Med J (2014) 0.75
Primary IgA and IgG subclass deficiency in a 17-year-old Pakistani girl: a case report. Cases J (2009) 0.75
Common variable immunodeficiency syndrome with right aortic arch: a case report. BMC Infect Dis (2004) 0.75
5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev (1980) 6.14
Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 5.88
Asthma mortality in Birmingham 1975-7: 53 deaths. Br Med J (1980) 5.07
Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci U S A (1975) 5.02
Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ (1997) 4.95
The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43
Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1975) 4.17
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell (1976) 3.82
Oxygen desaturation during endoscopy in the elderly. J R Coll Physicians Lond (1993) 3.37
Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol (1990) 3.20
In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 3.17
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12
Transcription in vitro by reovirus-associated ribonucleic acid-dependent polymerase. J Virol (1970) 3.07
Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus. Cell (1978) 3.06
Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1975) 3.04
Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology (1974) 2.83
5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73
Circumstances of death from asthma. Br Med J (Clin Res Ed) (1984) 2.71
Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells. J Virol (1975) 2.68
In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1974) 2.42
ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity (1997) 2.39
Unique mode of transcription in vitro by Vesicular stomatitis virus. Cell (1980) 2.36
Novel initiation of RNA synthesis in vitro by vesicular stomatitis virus. Nature (1975) 2.36
Rescue of synthetic analogs of genome RNA of human parainfluenza virus type 3. Virology (1993) 2.33
Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest (1998) 2.30
An infectious clone of human parainfluenza virus type 3. J Virol (1997) 2.28
A district confidential enquiry into deaths due to asthma. Thorax (1993) 2.18
Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys (1996) 2.15
Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell (1975) 2.15
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol (1981) 2.08
Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proc Natl Acad Sci U S A (1992) 2.03
Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry (1976) 1.99
Phosphorylation within a specific domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. Cell (1987) 1.92
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA. J Virol (1988) 1.91
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation. J Virol (1992) 1.88
Identification of a domain within the phosphoprotein of vesicular stomatitis virus that is essential for transcription in vitro. Proc Natl Acad Sci U S A (1986) 1.87
Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro. Biochem Biophys Res Commun (1985) 1.79
Parasitic infections of the lung: a guide for the respiratory physician. Thorax (2010) 1.78
Mapping and initiation studies on the leader RNA of vesicular stomatitis virus. Virology (1977) 1.78
Vesicular stomatitis virus NS proteins: structural similarity without extensive sequence homology. J Virol (1985) 1.73
Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase. J Virol (1993) 1.73
Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using a two-hybrid system. Proc Natl Acad Sci U S A (1993) 1.63
Initiation of reovirus mRNA synthesis in vitro. Nat New Biol (1971) 1.61
Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: analysis of phosphorylation status versus transcriptional activity. J Virol (1991) 1.60
Simultaneous pulmonary and cerebral oedema, and multiple CNS infarctions as complications of diabetic ketoacidosis: a case report. Diabet Med (2006) 1.60
ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol (2001) 1.60
The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus. Virology (1976) 1.60
The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores. Thorax (1994) 1.58
Resolution of multiple complexes of phosphoprotein NS with nucleocapsid protein N of vesicular stomatitis virus. J Virol (1988) 1.57
Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J (2001) 1.54
Referral for lung transplantation: experience of a Birmingham Adult Cystic Fibrosis Centre between 1987 and 1994. Thorax (1996) 1.54
Ventilation in a Birmingham intensive care unit 1993-1995: outcome for patients with chronic obstructive pulmonary disease. Respir Med (1998) 1.53
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Endoscopic transthoracic sympathectomy in the treatment of hyperhidrosis. Ann Surg (1992) 1.51
Does a doctor's dress-style matter? Med J Aust (1988) 1.49
RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 alphabetagamma for its activity. Proc Natl Acad Sci U S A (1998) 1.49
Complications of parotid surgery: the need for selectivity. Br J Surg (1989) 1.48
In vitro phosphorylation of NS protein by the L protein of vesicular stomatitis virus. J Gen Virol (1985) 1.48
RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology (1992) 1.44
In vitro RNA transcription by the New Jersey serotype of vesicular stomatitis virus. I. Characterization of the mRNA species. J Virol (1978) 1.44
Nocturnal hypoxaemia in cystic fibrosis: relationship to pulmonary function tests. Respir Med (1994) 1.44
Initiation of RNA synthesis in vitro by vesicular stomatitis virus. Role of ATP. J Biol Chem (1979) 1.43
Replication of RNA viruses. X. Replication of a natural 6 s RNA by the Q-beta RNA polymerase. J Mol Biol (1969) 1.42
Two methyltransferase activities in the purified virions of vesicular stomatitis virus. J Virol (1977) 1.42
Guanosine-5'-diphosphate at the 5' termini of reovirus RNA: evidence for a segmented genome within the virion. J Mol Biol (1971) 1.40
Anterior tibial artery embolectomy augmented by dynamic on-table angiography. Lancet (1991) 1.39
Specific interactions of vesicular stomatitis virus L and NS proteins with heterologous genome ribonucleoprotein template lead to mRNA synthesis in vitro. J Virol (1984) 1.39
Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. J Virol (1992) 1.38
Identification of promoter-proximal oligonucleotides and a unique dinucleotide, pppGpC, from in vitro transcription products of vesicular stomatitis virus. J Virol (1981) 1.38
Intramedullary spinal cysticercosis. Case report and review of literature. Clin Neurol Neurosurg (1987) 1.38
The life and work of the Birmingham radiologist Dr James Brailsford (1888-1961). J Med Biogr (2004) 1.38
Communication in surgical practice. J R Soc Med (1987) 1.38
Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. Eur J Immunol (1981) 1.36
Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. Proc Natl Acad Sci U S A (1982) 1.34
Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed) (1983) 1.34
Cellular protein kinase C isoform zeta regulates human parainfluenza virus type 3 replication. Proc Natl Acad Sci U S A (1995) 1.33
Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication. J Virol (1997) 1.31
Characterization of the in vitro system for the synthesis of mRNA from human respiratory syncytial virus. Virology (1993) 1.31
Transient hovering performance of hummingbirds under conditions of maximal loading. J Exp Biol (1997) 1.31
Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res (2001) 1.31
Genetically determined susceptibility to mycobacterial infection. J Clin Pathol (2008) 1.30
The transcription complex of vesicular stomatitis virus. Cell (1987) 1.30
High prevalence of subclinical hypothyroidism during first trimester of pregnancy in North India. Indian J Endocrinol Metab (2013) 1.30
Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med (2004) 1.30
Phosphoprotein NS of vesicular stomatitis virus: phosphorylated states and transcriptional activities of intracellular and virion forms. Virology (1986) 1.29
Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3. J Biol Chem (1996) 1.29
Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax (1996) 1.29
Crohn's or poisoning? Gut (1988) 1.29
In vitro synthesis of the full-length complement of the negative-strand genome RNA of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1980) 1.28
Relation of intra-splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells. Immunology (1984) 1.28
Absence of abdominal pain in elderly patients with peptic ulcer. Age Ageing (1984) 1.27
In vivo methylation of vesicular stomatitis virus and its host-cell messenger RNA species. Virology (1976) 1.27
Messenger RNA encoding the phosphoprotein (P) gene of human parainfluenza virus 3 is bicistronic. Virology (1986) 1.26
Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. Virology (2000) 1.26
Cytosine at the 3'-termini of reovirus genome and in vitro mRNA. Nat New Biol (1971) 1.25